Celularity Inc. said Nasdaq notified it on August 21, 2026, that it violated Listing Rule 5250(c)(1) by failing to file its Form 10-Q for the period ended June 30, 2026, while remaining delinquent on its March 31, 2026, Form 10-Q. Nasdaq requested a compliance plan by September 4, 2026, and any exception could last no longer than 180 calendar days from the initial delinquent filing's prescribed due date, or until November 16, 2026. Separately, Atlanta-based insurance holding company Atlantic American Corporation said Nasdaq notified it on August 20, 2026, that it had not filed its June 30, 2026, Form 10-Q and remained delinquent on its 2025 Form 10-K and March 31, 2026, Form 10-Q. Nasdaq granted Atlantic American an extension until October 12, 2026, after reviewing its compliance plan, while an updated plan concerning the June 30 Form 10-Q is due by September 4. Neither notice immediately affects the companies' stock listings or trading. Atlantic American shares rose 0.78% in regular trading to $1.30 and gained 20% after hours to $1.56. The company had a $26.52 million market capitalization, a 52-week range of $1.25 to $3.71, an RSI of 29.19, and a 62.10% 12-month decline.